title: Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury.
abstract: Previous studies have demonstrated that polydatin, a crystal component extracted from the root stem of the perennial herbage Polygonum Cuspidatum Sieb.et Zucc, exerts a neuroprotective effect on cerebral injury induced by ischemia/reperfusion. To investigate the possible mechanism of this action, we determined the effects of polydatin on the expression of cell adhesion molecules (CAMs) after ischemia-induced cerebral injury. Rats were treated with polydatin (i.v.) immediately after the operation of middle cerebral artery occlusion (MCAO) for 1 h. It was found that polydatin improved neurological deficits and reduced the volume of brain infarction. In addition, polydatin decreased the levels of CAMs relative to the control (MCAO alone); these included intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, L-selectin and Integrins. These results suggest that polydatin exerts protective effects likely via inhibition of the expression of various CAMs; polydatin may be a potential agent for treatment of brain injury associated with stroke.
authors.affiliation: Department of Pharmacology, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong, PR China.
authors.forename: Yufang
authors.initials: Y
authors.lastname: Cheng
authors.forename: Han-Ting
authors.initials: HT
authors.lastname: Zhang
authors.forename: Lisha
authors.initials: L
authors.lastname: Sun
authors.forename: Shenglan
authors.initials: S
authors.lastname: Guo
authors.forename: Shi
authors.initials: S
authors.lastname: Ouyang
authors.forename: Yanjun
authors.initials: Y
authors.lastname: Zhang
authors.forename: Jiangping
authors.initials: J
authors.lastname: Xu
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001921:Brain / Q000187:drug effects*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D015870:Gene Expression / Q000187:drug effects; D005960:Glucosides / Q000627:therapeutic use*; D007150:Immunohistochemistry / Q000379:methods; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism; D008297:Male; D019006:Neural Cell Adhesion Molecules / Q000145:classification / Q000502:physiology*; D009460:Neurologic Examination / Q000379:methods; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000473:pathology* / Q000517:prevention & control*; D013267:Stilbenes / Q000627:therapeutic use*; D019010:Vascular Cell Adhesion Molecule-1 / Q000235:genetics / Q000378:metabolism
chemical_list: D005960:Glucosides; D019006:Neural Cell Adhesion Molecules; D018696:Neuroprotective Agents; D013267:Stilbenes; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; C058229:polydatin